The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine
Open accessAbstract
BACKGROUND: Polydrug abuse is a known problem among opioid-dependent patients receiving opioid maintenance treatment (OMT). However, improved laboratory diagnostics is required to reveal polydrug abuse in its current scope. Furthermore, there are few studies focusing on the relationship between polydrug abuse and adequacy of the dose of OMT medicine. This study aimed to evaluate the polydrug abuse among opioid-dependent patients receiving OMT with inadequate (Group IA) and adequate (Group A) doses of OMT medicine as experienced by the patients. Craving for opioids and withdrawal symptoms were evaluated as indicators of the adequacy rating. METHODS: This is a retrospective register-based study of 60 OMT patients on either methadone or sublingual buprenorphine/naloxone medication, whose polydrug abuse was studied from urine samples by means of a comprehensive high-resolution mass spectrometry method. RESULTS: Inadequate doses of the OMT medicines were associated with higher subjective withdrawal scores and craving for opioids. Six groups of abused substances (benzodiazepines, amphetamines, opioids, cannabis, new psychoactive substances, and non-prescribed psychotropic medicines) were found among OMT patients. Group IA patients showed significantly more abuse of benzodiazepines and amphetamines than the Group A patients. All the new psychoactive substances and most of the non-prescribed psychotropic medicines were detected from the Group IA patients. There was no difference in the doses of the OMT medicine between Groups IA and A patients. CONCLUSIONS: Polydrug abuse, detected by definitive laboratory methods, was widespread and more common among Group IA than Group A patients, emphasizing the requirement for individual OMT medicine dose adjustment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, patients receiving opioid maintenance treatments frequently misuse other drugs, including alcohol, benzodiazepines, cannabis, and gabapentinoids (81, 82).”
From Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice (2019) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders
(2012) · SpringerReference · doi:10.1007/springerreference_121117 · Cited by 20,570
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Eap, C. B., Buclin, T., & Baumann, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00003 · Cited by 599 · cited 1×
“However, the blood concentration of methadone has large interindividual variation for a given dosage due to the interindividual variability of CYP enzymes and interactions between methadone and several medications [37].”
BackgroundTwo New Rating Scales for Opiate Withdrawal
Handelsman, L., Cochrane, K. J., Aronson, M. J., Ness, R., Rubinstein, K. J., & Kanof, P. D. (1987) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998709001515 · Cited by 599 · cited 1×
“withdrawal symptoms was based on the 13-item OOWS scale [29] which indicates each withdrawal symptom on a two-point scale (zero and one): where zero equals ‘absence of any symptom’, and one equals ‘presence of a symptom’.”
MethodThe clinical significance of drug craving
Tiffany, S. T., & Wray, J. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06298.x · Cited by 556 · cited 1×
“various substances and craving contains both automatic and cognition-controlled processes [43, 44].”
BackgroundMethadone maintenance at different dosages for opioid dependence
Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002208 · Cited by 406 · cited 1×
“Many OMT studies have targeted patients with heroin dependence and cocaine abuse [2, 3].”
BackgroundNovel psychoactive substances of interest for psychiatry
Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry · doi:10.1002/wps.20174 · Cited by 321 · cited 1×
“The LC-TOFMS database of this study did not include olanzapine and venlafaxine which both possess abuse liability [39].”
Method
Cited by
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
Wiese, B. M., & Wilson‐Poe, A. R. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0022 · Cited by 183
“in medication-assisted detoxification from opioids reported using cannabis when opioid maintenance doses were not high enough to prevent withdrawal and cravings.(114) However, some individuals reported that cannabis was often ineffective and sometimes wors-”
BackgroundRecommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus
Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1409722 · Cited by 141
Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice
Kakko, J., Alho, H., Baldacchino, A., Molina, R., Nava, F. A., & Shaya, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00592 · Cited by 140
“In addition, patients receiving opioid maintenance treatments frequently misuse other drugs, including alcohol, benzodiazepines, cannabis, and gabapentinoids (81, 82).”
BackgroundThe Next Stage of Buprenorphine Care for Opioid Use Disorder
Martin, S. A., Chiodo, L. M., Bosse, J. D., & Wilson, A. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1652 · Cited by 130
“Although inadequate MAT dosing has been related to increased polysubstance use (62), expecting OUD treatment to affect other substance use is unreasonable (38).”
BackgroundPolydrug use disorders in individuals with opioid use disorder
Hassan, A. N., & Foll, B. L. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.01.031 · Cited by 124
Metadata
- Authors
- Heikman, P. K., Muhonen, L. H., & Ojanperä, I. A.
- Affiliations
- University of Helsinki (FI)
- Corresponding author
- Heikman, Pertti Kalevi
- Venue
- BMC Psychiatry
- Published
- 2017-07-06
- Volume
- 17
- Issue
- 1
- Pages
- 245-245
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC5501578
- OpenAlex
- W2729557480
- Cited by
- 70
- References
- 43
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 11 · 2023: 8 · 2022: 15 · 2021: 6 · 2020: 14 · 2019: 8 · 2018: 3 · 2017: 2
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- WOS
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- polydrug abuse, opioid maintenance treatment, opioid use disorder, methadone, buprenorphine/naloxone, dose adequacy, opioid craving, withdrawal symptoms, benzodiazepine misuse, amphetamine abuse, new psychoactive substances, psychotropic drug abuse, urine drug testing, dose adjustment
- MeSH terms
- Adult, Analgesics, Opioid, Benzodiazepines, Buprenorphine, Female, Finland, Humans, Male, Methadone, Middle Aged, Opioid-Related Disorders, Psychotropic Drugs, Retrospective Studies, Substance-Related Disorders, Opiate Substitution Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine. https://app.cochat.ai/papers/10.1186/s12888-017-1415-y
- The paper
- Heikman, P. K., Muhonen, L. H., & Ojanperä, I. A. (2017). Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine. BMC Psychiatry. https://doi.org/10.1186/s12888-017-1415-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.